
Robert W. Downs
Examiner (ID: 17152)
| Most Active Art Unit | 2308 |
| Art Unit(s) | 2762, 4762, 2309, 2308, 2165 |
| Total Applications | 581 |
| Issued Applications | 448 |
| Pending Applications | 24 |
| Abandoned Applications | 109 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10489822
[patent_doc_number] => 20150374843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'MULTIVALENT CONSTRUCTS FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/689537
[patent_app_country] => US
[patent_app_date] => 2015-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 68508
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14689537
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/689537 | MULTIVALENT CONSTRUCTS FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS | Apr 16, 2015 | Abandoned |
Array
(
[id] => 12858172
[patent_doc_number] => 20180177898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => GLUCOSE ANALOGS FOR DIAGNOSIS OF DISEASE STATES
[patent_app_type] => utility
[patent_app_number] => 15/129255
[patent_app_country] => US
[patent_app_date] => 2015-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5560
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15129255
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/129255 | Glucose analogs for diagnosis states | Mar 25, 2015 | Issued |
Array
(
[id] => 10311670
[patent_doc_number] => 20150196673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'ANTICANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/669313
[patent_app_country] => US
[patent_app_date] => 2015-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14484
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14669313
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/669313 | Anticancer therapy | Mar 25, 2015 | Issued |
Array
(
[id] => 16413334
[patent_doc_number] => 10821196
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-03
[patent_title] => Substrate based PET imaging agents
[patent_app_type] => utility
[patent_app_number] => 14/643071
[patent_app_country] => US
[patent_app_date] => 2015-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22369
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14643071
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/643071 | Substrate based PET imaging agents | Mar 9, 2015 | Issued |
Array
(
[id] => 11204079
[patent_doc_number] => 09433690
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-09-06
[patent_title] => 'Radiopharmaceutical solutions with advantageous properties'
[patent_app_type] => utility
[patent_app_number] => 14/632849
[patent_app_country] => US
[patent_app_date] => 2015-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11651
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14632849
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/632849 | Radiopharmaceutical solutions with advantageous properties | Feb 25, 2015 | Issued |
Array
(
[id] => 11326111
[patent_doc_number] => 20160356723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'Light-Up Probes Based On Fluorogens With Aggregation Induced Emission Characteristics For Cellular Imaging And Drug Screening'
[patent_app_type] => utility
[patent_app_number] => 15/114692
[patent_app_country] => US
[patent_app_date] => 2015-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17049
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15114692
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/114692 | Light-Up Probes Based On Fluorogens With Aggregation Induced Emission Characteristics For Cellular Imaging And Drug Screening | Jan 26, 2015 | Abandoned |
Array
(
[id] => 11382870
[patent_doc_number] => 20170008926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'RARE EARTH MATERIAL-BINDING PEPTIDE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/113287
[patent_app_country] => US
[patent_app_date] => 2015-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12588
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15113287
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/113287 | Rare earth material-binding peptide and use thereof | Jan 20, 2015 | Issued |
Array
(
[id] => 10332002
[patent_doc_number] => 20150217006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'AL-F-18-LABELED, AL-F-19-LABELED AND GA-68-LABELED GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-ANTAGONISTS FOR IMAGING OF PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/599816
[patent_app_country] => US
[patent_app_date] => 2015-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15895
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14599816
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/599816 | AL-F-18-LABELED, AL-F-19-LABELED AND GA-68-LABELED GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-ANTAGONISTS FOR IMAGING OF PROSTATE CANCER | Jan 18, 2015 | Abandoned |
Array
(
[id] => 10305400
[patent_doc_number] => 20150190400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'THIOFLAVIN DERIVATIVES FOR USE IN THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER\'S DISEASE AND IN VIVO IMAGING AND PREVENTION OF AMYLOID DEPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/595949
[patent_app_country] => US
[patent_app_date] => 2015-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15655
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14595949
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/595949 | Thioflavin derivatives for use in the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition | Jan 12, 2015 | Issued |
Array
(
[id] => 12322893
[patent_doc_number] => 09943606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-17
[patent_title] => Dendritic polypeptide-based nanocarriers for the delivery of therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 14/594844
[patent_app_country] => US
[patent_app_date] => 2015-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12873
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14594844
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/594844 | Dendritic polypeptide-based nanocarriers for the delivery of therapeutic agents | Jan 11, 2015 | Issued |
Array
(
[id] => 13278465
[patent_doc_number] => 10150804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-11
[patent_title] => Compositions and methods for imaging cancer
[patent_app_type] => utility
[patent_app_number] => 15/109551
[patent_app_country] => US
[patent_app_date] => 2015-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 10719
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15109551
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/109551 | Compositions and methods for imaging cancer | Jan 1, 2015 | Issued |
Array
(
[id] => 11115327
[patent_doc_number] => 20160312301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'MICRORNA BIOMARKERS FOR OVARIAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/105763
[patent_app_country] => US
[patent_app_date] => 2014-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12423
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105763
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/105763 | MICRORNA BIOMARKERS FOR OVARIAN CANCER | Dec 21, 2014 | Abandoned |
Array
(
[id] => 10297644
[patent_doc_number] => 20150182644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 14/579157
[patent_app_country] => US
[patent_app_date] => 2014-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 19615
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14579157
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/579157 | Compounds and methods for the detection of TRPV-6 cancers and drug delivery | Dec 21, 2014 | Issued |
Array
(
[id] => 11106293
[patent_doc_number] => 20160303263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'RADIOTRACER COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/102952
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8986
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102952
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/102952 | Radiotracer compositions and methods | Dec 17, 2014 | Issued |
Array
(
[id] => 12015853
[patent_doc_number] => 09808541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-07
[patent_title] => 'Thioflavin derivatives for use in antemortem diagnosis of Alzheimer\'s disease and in vivo imaging and prevention of amyloid deposition'
[patent_app_type] => utility
[patent_app_number] => 14/571082
[patent_app_country] => US
[patent_app_date] => 2014-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 20
[patent_no_of_words] => 14189
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14571082
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/571082 | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition | Dec 14, 2014 | Issued |
Array
(
[id] => 11106289
[patent_doc_number] => 20160303258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'COMPOUNDS AND COMPOSITIONS FOR IMAGING GCC-EXPRESSING CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/100883
[patent_app_country] => US
[patent_app_date] => 2014-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 35470
[patent_no_of_claims] => 167
[patent_no_of_ind_claims] => 75
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15100883
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/100883 | COMPOUNDS AND COMPOSITIONS FOR IMAGING GCC-EXPRESSING CELLS | Dec 2, 2014 | Abandoned |
Array
(
[id] => 11077168
[patent_doc_number] => 20160274132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'MARKER OF CELL DEATH'
[patent_app_type] => utility
[patent_app_number] => 15/037360
[patent_app_country] => US
[patent_app_date] => 2014-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17107
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037360
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/037360 | Marker of cell death | Nov 26, 2014 | Issued |
Array
(
[id] => 17194187
[patent_doc_number] => 11162937
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Patient selection method for inflammation
[patent_app_type] => utility
[patent_app_number] => 15/037793
[patent_app_country] => US
[patent_app_date] => 2014-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 41
[patent_no_of_words] => 21245
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037793
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/037793 | Patient selection method for inflammation | Nov 18, 2014 | Issued |
Array
(
[id] => 12962617
[patent_doc_number] => 09873721
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-23
[patent_title] => Fluorescent fusion protein
[patent_app_type] => utility
[patent_app_number] => 14/543238
[patent_app_country] => US
[patent_app_date] => 2014-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 4158
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14543238
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/543238 | Fluorescent fusion protein | Nov 16, 2014 | Issued |
Array
(
[id] => 14818529
[patent_doc_number] => 10406250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Suicide contrast agents targeting HIV reservoirs for theranostic eradication
[patent_app_type] => utility
[patent_app_number] => 15/036512
[patent_app_country] => US
[patent_app_date] => 2014-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 33
[patent_no_of_words] => 20570
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036512
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/036512 | Suicide contrast agents targeting HIV reservoirs for theranostic eradication | Nov 13, 2014 | Issued |